RHEP · Regional Health Properties, Inc · Metrics
Market Cap
$4.08M
Shares
3.92M
Volume · Oct 20
3497
Avg daily vol (3M)
2499
RHEP metrics
71 of 122 screener metrics currently available.
Market overview
2 metricsShare price
$1.04
Market cap
$4.08M
Price action
20 metricsPrice change (1W)
-3.1%
Price change (30D)
+2.6%
Price change (3M)
+1.6%
Price change (6M)
-28.0%
Price change (YTD)
-19.0%
Price change (1Y)
-24.4%
Trailing year
Price change (5Y)
-86.2%
52-week high
$1.50
52-week low
$0.95
Change from 52-week high
-30.9%
Change from 52-week low
+9.1%
Annualized volatility
76.5%
Annualized volatility (3M)
—
Beta
-0.2
RSI (14D)
49.7
Price vs SMA 50
0.0%
Price vs SMA 200
-15.4%
Avg volume (3M)
2,434
Relative volume
2.9
Average dollar volume
$2,506
Company
3 metricsSector
Healthcare
Industry
Medical Care Facilities
Shares outstanding
3.92M
Valuation
12 metricsP / E (TTM)
0.5
Trailing earnings · reciprocal yield 214.2%
PEG ratio
—
EV / revenue
0.5×
reciprocal yield 194.8%
EV / EBITDA
9.7×
reciprocal yield 10.3%
EV / EBIT
26.6×
reciprocal yield 3.8%
P / sales
0.0×
reciprocal yield 2,004.9%
P / book
—
FCF yield
-96.9%
TTM · current market cap
Buyback yield
1.1%
P / FCF
—
P / operating cash flow
—
Earnings yield
100.1%
Historical valuation
8 metricsP / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
2.1×
reciprocal yield 47.5%
EV / revenue historical average (5Y)
2.1×
reciprocal yield 48.1%
EV / EBIT historical average (3Y)
162.3×
reciprocal yield 0.6%
EV / EBIT historical average (5Y)
146.9×
reciprocal yield 0.7%
EV / EBITDA historical average (3Y)
27.4×
reciprocal yield 3.7%
EV / EBITDA historical average (5Y)
24.5×
reciprocal yield 4.1%
Dividends & buybacks
7 metricsDividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
1.1%
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—
Earnings calendar
2 metricsNext earnings
—
Last earnings
—
Profitability
9 metricsGross margin
86.9%
Operating margin
1.9%
Trailing 12 months
Net margin
5.0%
Gross profit (TTM)
—
Operating profit (TTM)
$1.57M
Net income (TTM)
$4.07M
Trailing 12 months
Diluted EPS (TTM)
$2.22
FCF margin
-4.8%
Effective tax rate
—
Growth
11 metricsRevenue growth YoY
+143.0%
Year over year
Net income growth YoY
—
Revenue (TTM)
$81.52M
Trailing 12 months
EPS growth YoY
—
Shares change YoY
+83.3%
Year over year · more shares
Revenue CAGR (3Y)
+14.0%
Revenue CAGR (5Y)
+24.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—
Quality
14 metricsReturn on equity
—
Return on assets
6.0%
Debt / equity
—
Current ratio
0.7
EBITDA (TTM)
$4.31M
Free cash flow (TTM)
−$3.94M
Quick ratio
0.6
Interest coverage
0.6
Net debt / EBITDA
8.8
Return on invested capital
—
Trailing 12 months
Net cash
−$37.79M
Latest balance sheet
Cash & equivalents
$1.70M
Total assets
$67.96M
Total debt
$39.49M
Cash flow & spend
7 metricsOperating cash flow (TTM)
−$2.57M
Capital expenditures (TTM)
$1.37M
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
$355,000
R&D / revenue
—
Stock compensation / revenue
0.4%
Ownership (13F)
9 metrics13F filers
—
13F filer change QoQ
—
Institutional ownership
—
Conviction holders (share of 13F filers)
—
Crowding (high-turnover and private-fund holders)
—
Private-fund adviser ownership
—
Active holders' share change QoQ
—
Holder tenure
—
Price vs estimated holder cost
—
Ownership (registered funds)
1 metricsIndex-fund ownership
0.0%
Short interest
3 metricsShort interest
0.2%
Latest settlement · 1.0 days to cover
Days to cover
1.0d
Short-squeeze score
27 / 100
Insider activity
2 metricsNet insider buying (90D)
—
Insider-sentiment score
—
Risk flags
1 metricsGoing concern
—